Concepedia

Roman Groisberg

RG

Statistics

Publications

21

Citations

1.1K

H-Index

15

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Rutgers, The State University of New Jersey

Rutgers Cancer Institute

Sarah Cannon

Merck & Co., Inc., Rahway, NJ, USA (United States)

Roman Groisberg is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2017–2024

21

Publications

21

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Matteo Palmeri, Janice M. Mehnert, Ann W. Silk et al. · ESMO Open · 2021 · 333 citations · Full text

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Roman Groisberg, David S. Hong, Behrang Amini et al. · Journal for ImmunoTherapy of Cancer · 2017 · 142 citations · Full text

, , +17

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas

Roman Groisberg, David S. Hong, Vijaykumar Holla et al. · Oncotarget · 2017 · 90 citations · Full text

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study

Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa et al. · Journal of Clinical Oncology · 2023 · 87 citations · Full text

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

Shang-Jui Wang, Karishma Khullar, Sinae Kim et al. · Journal for ImmunoTherapy of Cancer · 2020 · 58 citations · Full text

1–5 of 21